Back to RLMD

Spruce Street Capital LP → RLMD

Spruce Street Capital LP RLMD Position History

Relmada Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$26.1M
Q3 2026
Peak value
$44.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$19.7M
Q1 2026$43M
Q2 2026$44.2M
Q3 2026$26.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$26.1M6.91M——
Q2 2026$44.2M6.39M——
Q1 2026$43M6.26M——
Q4 2025$19.7M4.09M——

Other funds holding RLMD

Other Spruce Street Capital LP positions

KNSA

KINIKSA PHARMACEUTICALS INTL

$68.5M
KNSA

KINIKSA PHARMACEUTICALS INTL

$58.7M
RLAY

RELAY THERAPEUTICS INC

$55.8M
RLAY

RELAY THERAPEUTICS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$44.7M
ANRO

ALTO NEUROSCIENCE INC

$42.8M
ALKS

ALKERMES PLC

$38.4M